№1-2(8) 2025

DOI 10.37219/2528-8253-2025-1-2-46

Tytarchuk OK, Tsvirinko IR, Zabolotna DD
EXTRAOSSEOUS AMELOBLASTOMA OF THE MAXILLARY SINUS: A CLINICAL CASE
Tytarchuk Oleksandra K
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine
Intern
E-mail: sasha.tytarchuk@gmail.com
ORCID ID: https://orcid.org/0009-0004-0761-0060
Tsvirinko Irina R
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine
Department of Rhinology and Allergology with a group of radiology
Researcher
PhD
E-mail: tsira31@gmail.com
ORCID ID: https://orcid.org/0000-0003-2186-1312
Zabolotna Diana D
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine.
Head of Department of Rhinology and Allergology with a group of radiology
Doctor of Medical Sciences, Professor
E-mail: dianazab@ukr.net
ORCID ID: https://orcid.org/0000-0001-7807-8148

Abstract

Relevance: Ameloblastoma is a rare benign epithelial tumour, considered the most aggressive among benign odontogenic tumours, with a recurrence risk of up to 50% within the first 5 years after treatment. Tumours of the upper jaw are more complex due to their proximity to vital anatomical structures, requiring special attention in diagnosis and treatment.

Objective: To draw attention to maxillary ameloblastoma as a rare, aggressive, benign tumour through a clinical case example, highlighting treatment methods and recurrence prevention strategies.

Materials and Methods: A patient with complaints of unilateral nasal congestion, difficulty in nasal breathing, and headaches for 6 months was examined at the Department of Inflammatory Diseases of the State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Sciences of Ukraine”. Radiological imaging was performed, specifically computed tomography with intravenous contrast enhancement using Tomohexol.

Results and Discussion: CT revealed a soft tissue mass with irregular, indistinct contours on the right side, extending from the upper-medial parts of the maxillary sinus into the nasal cavity. Remodelling of the posterior-lateral wall of the right maxillary sinus was observed.

A decision was made to perform endoscopic endonasal tumor removal. During surgery, endoscopic partial septoplasty, right-sided endonasal partial antrostomy type II (TEMP-II), ethmoidotomy, and frontotomy were performed.

Extraosseous/peripheral ameloblastoma is the rarest variant of ameloblastoma, predominantly affecting individuals aged 40 to 60, with a slight male predominance – fully consistent with our clinical case. Typically, this tumor does not involve bone destruction, although superficial bone erosion may occur, which distinguishes our patient’s case from descriptions in the literature. The treatment of choice is complete tumour resection with 1-2 cm margins within healthy tissue. There is no evidence supporting chemotherapy or radiation therapy.

Conclusions. Ameloblastoma remains poorly understood and, despite its rarity, can affect the maxillary sinuses. Radical resection and regular follow-up are key to successful treatment, as this tumour, despite its benign nature, carries a high risk of recurrence.

Keywords: Ameloblastoma, maxilla, neoplasm, odontogenic tumour.

References

  1. Nakamura N, Mitsuyasu T, Higuchi Y, Sandra F, Ohishi M. Growth characteristics of ameloblastoma involving the inferior alveolar nerve: A clinical and histopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 May;91(5):557-62. doi: 10.1067/moe.2001.113110.
  2. Flint PW, Haughey BH, Lund VJ, Robbins TK, Thomas JR, Lesperance MM, Francis HW. Cummings Otolaryngology. Head and Neck Surgery, 3-Volume Set. 7th Elsevier; 2020. 3568 p.
  3. Robert EM, Diane S. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Chicago, Ill, USA: Quintessence Publishing Company; 2003. 908 p.
  4. Masthan KMK, Anitha N, Krupaa J, Manikkam S. Ameloblastoma. J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S167-70. doi: 10.4103/0975-7406.155891.
  5. Chaudhary Z, Sangwan V, Pal US, Sharma P. Unicystic ameloblastoma: A diagnostic dilemma. Natl J Maxillofac Surg. 2011 Jan;2(1):89-92. doi: 10.4103/0975-5950.85863.
  6. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors.  WHO classification of head and neck tumours. WHO Classification of Tumours, 4th, Vol. 9. Lyon: International Agency for Research on Cancer; 2017.
  7. Palanisamy JC, Jenzer AC. Ameloblastoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. 2023 Jul 3. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545165/.
  8. Brown NA, Betz BL. Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries. Biomark Cancer. 2015 Oct 4;7(Suppl 2):19-24. doi: 10.4137/BIC.S29329.
  9. Soluk-Tekkesin M, Wright JM. The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. Turk Patoloji Derg. 2022;38(2):168-184. doi: 10.5146/tjpath.2022.01573.
  10. Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):86-99. doi: 10.1016/0964-1955(94)00037-5.
  11. Ram H, Mohammad Sh, Husain N, Gupta PN. Ameloblastic Carcinoma. J Maxillofac Oral Surg. 2010 Dec;9(4):415-9. doi: 10.1007/s12663-010-0169-6.
  12. Fiedler LS, Wunsch A. Ameloblastoma of the maxillary sinus: conservative surgical management considering high recurrence risk potential. BMJ Case Rep. 2021 May 13;14(5):e241487. doi: 10.1136/bcr-2020-241487.
  13. Turri-Zanoni M, Battaglia P, Karligkiotis A, Lepera D, Zocchi J, Dallan I, Bignami M, Castelnuovo P. Transnasal endoscopic partial maxillectomy: Operative nuances and proposal for a comprehensive classification system based on 1378 cases. Head Neck. 2017 Apr;39(4):754-766. doi: 10.1002/hed.24676.